Current Surgical Receives $400k Grant from NIH's National Cancer Institute to Develop Surgery Platform for Early-Stage Cancer
Summary
The grant, awarded by the NIHs National Cancer Institute (NCI), will be used to develop and validate the companys technology in a preclinical setting.Cancer continues to be a leading cause of death worldwide, with more than 18 million new cases detected every year. Their smart surgical needle technology combines high resolution sensors and real-time image analysis into one tool, giving doctors precise control and feedback while destroying tumors. As a result, surgeons will be able to treat any solid tumor in any location allowing millions of patients to receive curative surgery without the traditional limitations. For more information about cancer, please visit the NCI website at cancer.gov or call NCIs contact center, the Cancer Information Service, at 1-800-4-CANCER (1-800-422-6237).About the National Institutes of Health (NIH)NIH, the nations medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases.